Please login to the form below

Not currently logged in

emerging markets

This page shows the latest emerging markets news and features for those working in and with pharma, biotech and healthcare.

Pfizer’s COVID-19 vaccine yields $3.5bn in first quarter sales

Pfizer’s COVID-19 vaccine yields $3.5bn in first quarter sales

Elsewhere, Pfizer reported a 25% increase in sales for anticoagulant med Eliquis, led by growth in the US, emerging markets and developed Europe, as well as an 88% operational growth for ... Pfizer’s Janus kinase (JAK) inhibitor Xeljanz also grew by 18%

Latest news

More from news
Approximately 13 fully matching, plus 356 partially matching documents found.

Latest Intelligence

  • Back to the future Back to the future

    Business models that aimed to compete on customer intimacy were polarising between small audiences – so called health concierges – and mass markets, which is Fitbit’s emerging model. ... By and large, I feel pretty vindicated. The six great shifts

  • Pharma funding and M&A in 2020 Pharma funding and M&A in 2020

    As we see with Takeda – and as we’ve seen with other industries, notably tech – companies from fast- growing emerging markets continue to rise.

  • BRIC markets BRIC markets

    The idea was to illustrate the growing importance of emerging economies relative to developed markets and to encourage the G7 to factor them into policymaking. ... He added: “The hype about BRIC markets is cooler than it used to be.

  • The mission matters The mission matters

    Developed and emerging markets differ greatly but there are also great differences between developed markets, such as Europe and the US. ... And within markets, therapy areas differ hugely, ranging from rare diseases and oncology to primary care and

  • Leading AstraZeneca’s return to growth in Europe Leading AstraZeneca’s return to growth in Europe

    Now the business has two particularly strong growth drivers: emerging markets, most especially China, and oncology, where a triumvirate of drugs – Tagrisso, Imfinzi and Lynparza – have hit a major growth phase. ... So does AstraZeneca believe there

More from intelligence
Approximately 14 fully matching, plus 62 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 35 partially matching documents found.

Latest from PMHub

  • Webcast

    China: How pharma can maximize success in this rapidly changing emerging market. ... Watch this webcast in which Research Partnership's emerging market experts explore the recent 2020 healthcare reforms, digital transformations as a result of COVID-19,

  • Windrose Consulting Group Windrose Consulting Group

    Follow on twitter. Amy Morgan. Head of Emerging Markets, UK. ... Windrose Consulting Group acquires Parioforma as part of its global growth strategy to further enhance its capabilities in non-traditional markets.

  • Article: Spotlight on Mexico

    Healthcare under AMLO – One year on. In this article, Rachel Howard and local expert Dr Xavier Tello, discuss the latest changes in the healthcare system and consider what they mean for pharmaceutical manufacturers wishing to enter the Mexican

  • News: Mandira Kar joins London Headquarters as Qualitative Research Director

    She has previously worked in a wide range of research industries including consumer and digital and has experience in many global markets, especially emerging markets, having lived and worked for a

  • Article: Market access in Brazil

    All eyes on Spinraza. Director Rachel Howard asks, “What does Brazil’s unprecedented risk-sharing agreement in Spinal Muscular Atrophy (SMA) mean for the future of market access in Brazil? In April 2019, Brazilian Health Minister Luiz Henrique

More from PMHub
Approximately 68 fully matching, plus 40 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs


Add my company

ROAD is a digital PR and communications consultancy specialising in promoting the innovators that shape our future health and wellbeing....

Latest intelligence

Personalised medicine AI
How early-stage clinical research is facilitating the new wave of personalised medicines
By Jorg Taubel...
patient diversity buckland
Patient diversity in clinical trials needs to be centre stage
By Danny Buckland...
Why empathy in digital patient recruitment is vital
This is where empathy mapping can be incredibly effective....